-transparent.png){kind=logo}
Noradrenaline (1-10 microM) inhibited Ca2+-induced insulin secretion from electrically permeabilised islets of Langerhans with an efficacy similar to that for inhibition of glucose-induced insulin secretion from intact islets. The inhibition of insulin secretion from permeabilised islets was blocked by the alpha 2-adrenoreceptor antagonist, yohimbine. Adenosine 3',5'-cyclic monophosphate (cAMP) did not relieve the noradrenaline inhibition of Ca2+-induced secretion from the permeabilised islets, although noradrenaline did not affect the secretory responses to cAMP at substimulatory (50 nM) concentrations of Ca2+. These results suggest that catecholamines do not inhibit insulin secretion solely by reducing B-cell adenylate cyclase activity, and imply that one site of action of noradrenaline is at a late stage in the secretory process.
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
August 1989,
Biochemical and biophysical research communications,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
March 1980,
Diabetologia,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
October 1985,
FEBS letters,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
April 1981,
Diabetes,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
March 1995,
Acta diabetologica,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
April 1992,
Journal of molecular endocrinology,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
September 1973,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
July 1987,
Biochimica et biophysica acta,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
August 1992,
The Biochemical journal,
P M Jones, and
J M Fyles, and
S J Persaud, and
S L Howell
June 1990,
Biochemical Society transactions,
